- Home
- MODG vs BEAM Comparison
MODG vs BEAM Comparison
Compare MODG & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MODG
- BEAM
- Stock Information
- Founded
- MODG 1982
- BEAM 2017
- Country
- MODG United States
- BEAM United States
- Employees
- MODG N/A
- BEAM N/A
- Industry
- MODG Recreational Games/Products/Toys
- BEAM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MODG Consumer Discretionary
- BEAM Health Care
- Exchange
- MODG Nasdaq
- BEAM Nasdaq
- Market Cap
- MODG 1.8B
- BEAM 1.7B
- IPO Year
- MODG 1992
- BEAM 2020
- Fundamental
- Price
- MODG $9.56
- BEAM $16.36
- Analyst Decision
- MODG Buy
- BEAM Strong Buy
- Analyst Count
- MODG 8
- BEAM 10
- Target Price
- MODG $10.19
- BEAM $48.56
- AVG Volume (30 Days)
- MODG 2.9M
- BEAM 2.4M
- Earning Date
- MODG 08-06-2025
- BEAM 08-05-2025
- Dividend Yield
- MODG N/A
- BEAM N/A
- EPS Growth
- MODG N/A
- BEAM N/A
- EPS
- MODG N/A
- BEAM N/A
- Revenue
- MODG $4,140,100,000.00
- BEAM $60,272,000.00
- Revenue This Year
- MODG N/A
- BEAM N/A
- Revenue Next Year
- MODG $1.47
- BEAM $17.95
- P/E Ratio
- MODG N/A
- BEAM N/A
- Revenue Growth
- MODG N/A
- BEAM N/A
- 52 Week Low
- MODG $5.42
- BEAM $13.53
- 52 Week High
- MODG $11.41
- BEAM $35.25
- Technical
- Relative Strength Index (RSI)
- MODG 52.60
- BEAM 38.14
- Support Level
- MODG $9.12
- BEAM $16.29
- Resistance Level
- MODG $10.08
- BEAM $17.64
- Average True Range (ATR)
- MODG 0.46
- BEAM 0.80
- MACD
- MODG -0.00
- BEAM 0.01
- Stochastic Oscillator
- MODG 71.05
- BEAM 28.90
About MODG Topgolf Callaway Brands Corp.
Topgolf Callaway Brands Corp is a modern golf and active lifestyle company that provides world-class golf entertainment experiences, designs and manufactures premium golf equipment, and sells golf and active lifestyle apparel and other accessories through brands such as, Topgolf, Callaway Golf, Odyssey, TravisMathew, Jack Wolfskin, OGIO and Toptracer. The company's reportable segments are; Topgolf, Golf Equipment and Active Lifestyle. Majority of the revenue is generated from its Topgolf segment which is predominantly comprised of service revenues and expenses from the company operated Topgolf venues, Toptracer ball-flight tracking technology, and WGT digital golf game. Geographically, majority of the revenue for the company is derived from United States.
About BEAM Beam Therapeutics Inc.
Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company views its operations and manages its business in one operating segment, operating exclusively in the United States.